Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > 2.5 Million Shares Cancelled

<< Previous

Bullboard Posts

Next >>

Comment by porksnifferon Aug 12, 2021 10:37am

119 Views

Post# 33691331

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:2.5 Million Shares Cancelled

People are in for a nasty surprise here when this gets taken private for a song. The flipping of shareholder base continues as the JRG 'believers' have accepted his total failure and are selling out at large losses. Next step....reduce the float, cancel as much stock as possible with shareholder money to make the the acqusition tens of millions cheaper for the family. Then throw a tiny premium and take the company as the 'new' shareholders will be making money and glad to sell. The writing is on the wall. Meir's ominous warning has come true, every word of it.

<< Previous

Bullboard Posts

Next >>

This gambling tech stock might be the safest bet you’ll make this year